These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vaccine Prevention of Herpes Zoster in Organ Transplant Recipients: A Busy Intersection of Immune Responses to Foreign Antigens. Miller G Clin Infect Dis; 2020 Jan; 70(2):191-192. PubMed ID: 30843045 [No Abstract] [Full Text] [Related]
6. [Herpes zoster and post-herpetic neuralgia in older adults]. Lang PO; Zarate-Lagunes M; Pautex S Rev Med Suisse; 2008 Nov; 4(178):2398-402, 2404. PubMed ID: 19051627 [TBL] [Abstract][Full Text] [Related]
7. In adults ≥ 70 years of age, an adjuvanted herpes zoster subunit vaccine reduced herpes zoster at a mean 3.7 years. Sacks HS Ann Intern Med; 2017 Jan; 166(2):JC5. PubMed ID: 28114461 [No Abstract] [Full Text] [Related]
9. Administrative Data to Explore the Role of Family History as a Risk Factor for Herpes Zoster. Harpaz R; Dahl RM Mayo Clin Proc; 2018 Jun; 93(6):747-751. PubMed ID: 29731177 [TBL] [Abstract][Full Text] [Related]
11. Herpes zoster vaccine brings relief for the elderly. Morrow T Manag Care; 2006 Dec; 15(12):57-8. PubMed ID: 17260848 [No Abstract] [Full Text] [Related]
12. The Herpes Zoster Vaccine in Rheumatic Diseases: Duration of Response. Shirley E; Chakravarty EF J Rheumatol; 2017 Jul; 44(7):968-969. PubMed ID: 28668813 [No Abstract] [Full Text] [Related]
13. Anterior Segment Complications Associated With the Live Herpes Zoster Vaccine. Kim DH Cornea; 2019 Feb; 38(2):e5. PubMed ID: 30431474 [No Abstract] [Full Text] [Related]
14. Vaccine-strain herpes zoster found in the trigeminal nerve area in a healthy child: A case report. Iwasaki S; Motokura K; Honda Y; Mikami M; Hata D; Hata A J Clin Virol; 2016 Dec; 85():44-47. PubMed ID: 27835757 [TBL] [Abstract][Full Text] [Related]
15. [The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines]. Afonina NM; Mikheeva IV Ter Arkh; 2013; 85(11):130-3. PubMed ID: 24432613 [TBL] [Abstract][Full Text] [Related]
16. Disseminated varicella zoster virus in an immunized child as the acquired immunodeficiency syndrome-defining illness. Chilek K; Routhouska S; Tamburro J Pediatr Dermatol; 2010; 27(2):192-4. PubMed ID: 19686302 [TBL] [Abstract][Full Text] [Related]
17. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia. Holcomb K; Weinberg JM J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial. Godeaux O; Kovac M; Shu D; Grupping K; Campora L; Douha M; Heineman TC; Lal H Hum Vaccin Immunother; 2017 May; 13(5):1051-1058. PubMed ID: 28068212 [TBL] [Abstract][Full Text] [Related]
19. Vaccine-Strain Herpes Zoster Ophthalmicus in a 14-month-old Boy Prompting an Immunodeficiency Workup: Case Report and Review of Vaccine-strain Herpes Zoster. Detty SQ; Peebles JK; Guerrieri JM; Seroogy CM; Struck MC; Arkin LM; Henderson SL Pediatr Infect Dis J; 2020 Feb; 39(2):e25-e27. PubMed ID: 31929435 [TBL] [Abstract][Full Text] [Related]
20. Herpes Zoster Vaccine: Time for a Boost? Reddy KP J Gen Intern Med; 2017 Feb; 32(2):145-147. PubMed ID: 27730484 [No Abstract] [Full Text] [Related] [Next] [New Search]